Emily Peterson Alva insider trades

Open-market stock purchases and sales by Emily Peterson Alva, Director at Amneal Pharmaceuticals, Inc, from SEC Form 4 filings since May 7, 2018.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +55%.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • AMRX Amneal Pharmaceuticals, Inc: 1 sale, last May 6, 2025
  • ALKS Alkermes plc.: 1 buy, last Jun 29, 2024

Get free alerts when Emily Peterson Alva files a new trade →